What is HIT's health score?

Health In Tech, Inc. (HIT) has a TradeApes health score of 54 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is HIT's estimated fair value?

Based on our 5-year discounted cash flow model, Health In Tech, Inc.'s estimated fair value is $0.8 per share, representing a -19.5% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is HIT undervalued or overvalued?

Our model currently rates HIT as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for HIT... Refresh in a moment for the full analysis.

Health In Tech, Inc. (HIT)

Financials Fair Value low mixed

$0.99

Updated: 2026-05-30

TradeApes Score

Financial Strength

50 Mixed

Operating Trend

63 Healthy

Relative Value

40 Weak

Capital Allocation

50 Mixed

Risk

80 Strong

Est. Fair Value $0.8

DCF Upside -19.5%

Sector Rank #441 of 6417

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− FCF deteriorating — free cash flow down more than 25% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.